Building a Document Analysis Pipeline for Regulatory Filings
Table of Contents
Why Regulatory Documents Are Hard
Regulatory submissions — FDA New Drug Applications, EMA Marketing Authorisation Applications, SEC filings — share several characteristics that make manual analysis slow:
- Volume: a full NDA can run to 100,000+ pages
- Structure: content is distributed across modules with complex cross-references
- Implicit claims: risk assessments embed assumptions never stated explicitly
- Temporal layering: amendments, supplements, and correspondence accumulate over years
Configuring the Pipeline
For regulatory documents, we recommend the following configuration:
| |
Key Outputs
Safety Signal Map
All adverse events reported across clinical modules are aggregated by system organ class, with frequency and severity data extracted and tabulated.
Commitment Register
Post-approval commitments are extracted as structured items, each linked to the section of the submission where they appear.
Cross-Module Consistency Check
assay.it flags claims that appear in one module but are contradicted or unsubstantiated in another — a common source of regulatory queries.
Integration
Output is delivered in structured JSON-LD and can be imported directly into regulatory information management systems or linked to dossier management platforms via our API.